Bisphosphate therapy with zoledronate or tenofovir switching to improve low bone mineral density in HIV-infected adults: A strategic randomised trial

Ebeling, Peter (Primary Chief Investigator (PCI))
Hoy, Jennifer (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/12 → 31/12/15

Funding

National Health & Medical Research Council (NHMRC): AUD20,160.00

Related content

Research Output

Do people with HIV infection have a higher risk of fracture compared with those without HIV infection?

Research output: Contribution to journal › Review Article › Other › peer-review

Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV

Research output: Contribution to journal › Article › Research › peer-review